» Articles » PMID: 20504027

Molecular Mechanism of the Glycosylation Step Catalyzed by Golgi Alpha-mannosidase II: a QM/MM Metadynamics Investigation

Overview
Journal J Am Chem Soc
Specialty Chemistry
Date 2010 May 28
PMID 20504027
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Golgi alpha-mannosidase II (GMII), a member of glycoside hydrolase family 38, cleaves two mannosyl residues from GlcNAcMan(5)GlcNAc(2) as part of the N-linked glycosylation pathway. To elucidate the molecular and electronic details of the reaction mechanism, in particular the conformation of the substrate at the transition state, we performed quantum mechanics/molecular mechanics metadynamics simulations of the glycosylation reaction catalyzed by GMII. The calculated free energy of activation for mannosyl glycosylation (23 kcal/mol) agrees very well with experiments, as does the conformation of the glycon mannosyl ring in the product of the glycosylation reaction (the covalent intermediate). In addition, we provide insight into the electronic aspects of the molecular mechanism that were not previously available. We show that the substrate adopts an (O)S(2)/B(2,5) conformation in the GMII Michaelis complex and that the nucleophilic attack occurs before complete departure of the leaving group, consistent with a D(N)A(N) reaction mechanism. The transition state has a clear oxacarbenium ion (OCI) character, with the glycosylation reaction following an (O)S(2)/B(2,5) --> B(2,5) [TS] --> (1)S(5) itinerary, agreeing with an earlier proposal based on comparing alpha- and beta-mannanases. The simulations also demonstrate that an active-site Zn ion helps to lengthen the O2'-H(O2') bond when the substrate acquires OCI character, relieving the electron deficiency of the OCI-like species. Our results can be used to explain the potency of recently formulated GMII anticancer inhibitors, and they are potentially relevant in deriving new inhibitors.

Citing Articles

Digging out the Molecular Connections between the Catalytic Mechanism of Human Lysosomal α-Mannosidase and Its Pathophysiology.

Di Geronimo B, Mandl S, Alonso-Gil S, Zagrovic B, Reibnegger G, Nusshold C J Chem Inf Model. 2025; 65(5):2650-2659.

PMID: 39976451 PMC: 11898060. DOI: 10.1021/acs.jcim.4c02229.


An Unusual His/Asp Dyad Operates Catalysis in Agar-Degrading Glycosidases.

Sagiroglugil M, Nin-Hill A, Ficko-Blean E, Rovira C ACS Catal. 2024; 14(22):16897-16904.

PMID: 39569157 PMC: 11574756. DOI: 10.1021/acscatal.4c04139.


-cyclosulfamidate mannose-configured cyclitol allows isoform-dependent inhibition of GH47 α-d-mannosidases through a bump-hole strategy.

Males A, Kok K, Nin-Hill A, de Koster N, van den Beukel S, Beenakker T Chem Sci. 2023; 14(46):13581-13586.

PMID: 38033892 PMC: 10685318. DOI: 10.1039/d3sc05016e.


RNA-seq analysis identifies age-dependent changes in expression of mRNAs - encoding N-glycosylation pathway enzymes in mouse gonadotropes.

McDonald R, Larsen M, Liu Z, Southekal S, Eudy J, Guda C Mol Cell Endocrinol. 2023; 574:111971.

PMID: 37301504 PMC: 10528389. DOI: 10.1016/j.mce.2023.111971.


In silico modelling of the function of disease-related CAZymes.

Nin-Hill A, Piniello B, Rovira C Essays Biochem. 2023; 67(3):355-372.

PMID: 36912236 PMC: 10154626. DOI: 10.1042/EBC20220218.